Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

481
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
481
Teratogenicity01:07

Teratogenicity

3.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.

The Journal of investigative dermatology·2026
Same author

Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus.

EULAR rheumatology open·2026
Same author

[Interdisciplinary Collaboration between Social Service and Case Management in Child and Adolescent Psychiatry: A Qualitative Study of Barriers, Facilitators and the Family Caregiver Perspective].

Psychiatrische Praxis·2026
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

Development of a Core Outcome Domain Set for Facial Aging.

JAMA dermatology·2026
Same author

Anthropometric patterns in children with moderate-to-severe atopic dermatitis: Cross-sectional insights from the TREATkids cohort.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Related Experiment Video

Updated: Nov 1, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.8K

Prenatal Methamphetamine Exposure: Effects on Child Development–A Systematic Review.

Lorenz Harst1, Stefanie Deckert, Frederik Haarig

  • 1Center for Evidence-based Healthcare, University Hospital Dresden, Dresden, Germany; Division of Neonatology and Pediatric Intensive Care Medicine, Department of Pediatrics, University Hospital Dresden, Dresden, Germany; Center for Feto-Neonatal Health, University Hospital Dresden, Dresden, Germany.

Deutsches Arzteblatt International
|June 18, 2021
PubMed
Summary
This summary is machine-generated.

Prenatal methamphetamine exposure (PME) in newborns is linked to lower birth weight and developmental issues. Early intervention and prevention are crucial for affected families.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

436
Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

9.9K

Related Experiment Videos

Last Updated: Nov 1, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.8K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

436
Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

9.9K

Area of Science:

  • Perinatal Medicine
  • Developmental Psychology
  • Public Health

Background:

  • Methamphetamine use prevalence in Germany is 1.9% among 15-34 year olds.
  • Increasing incidence of prenatal methamphetamine exposure (PME) in newborns.
  • In 2014, Saxony reported 4 PME cases per 1000 live births.

Purpose of the Study:

  • To systematically review the effects of PME on neonatal health and long-term child development.
  • To assess the methodological quality of observational studies with control groups.

Main Methods:

  • Systematic review of publications from January 1990 to November 2019.
  • Inclusion of observational studies with control groups.
  • Meta-analysis of data from 4446 mother-child pairs with PME and 43,778 controls.

Main Results:

  • PME associated with lower birth weight, shorter body length, and smaller head circumference.
  • Developmental differences persist into toddler years.
  • Increased psychological and neurocognitive abnormalities in PME children, exacerbated by adverse environments.

Conclusions:

  • Early, interdisciplinary treatment for mothers, children, and families affected by PME is essential.
  • Structured preventive measures for methamphetamine use are critical.